CHICAGO (Reuters) - A once-a-day pill helped completely rebuild bone in rodents with severe osteoporosis, a finding that could lead to a new class of drugs to treat the brittle-bone disease in humans, U.S. researchers said. The team tested a compound that blocks the production of serotonin produced in the gut in mice and rats with a severe form of ...

LONDON (Reuters) - Dementia costs Britain 23 billion pounds ($37 billion) a year, more than cancer and heart disease combined, and the number of sufferers is expected to rise nearly 20 percent to over a million by 2025, experts said Wednesday. A study for the Alzheimer's Research Trust (ART) by Oxford University researchers found that the cost of caring for ...

NEW YORK (Reuters Health) - Men with impaired brain function may be at higher risk of suffering a stroke, even if these impairments are quite minor, a new study published today in the journal Neurology hints. Several studies have suggested a link between seriously impaired cognitive function and stroke, Dr. Bernice Wiberg of Uppsala University in Sweden and her colleagues note ...